Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Drug company (FDA labeler)

Alembic Pharmaceuticals Inc.

NDC labeler code: 62332

What is a labeler?

The company whose name is on the package and in the FDA’s National Drug Code (NDC) Directory. It may make the medicine itself or sell medicine made by another company. The first part of every NDC code identifies the labeler.

Official FDA data only

Products, approvals and recalls come from the FDA (NDC Directory, Drugs@FDA, enforcement reports). Recalls are linked to this company by the NDC labeler code on the recalled product.

Questions about your medicine: ask your doctor or pharmacist. In an emergency, call 911.

At a glance

491Products (NDC)

Prescription medicines

Show the other 122 medicines

FDA applications for these products

  • NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
  • ANDA: Abbreviated New Drug Application: how a generic version is approved.
ApprovedApplicationMedicineSponsor
October 15, 2026ANDA217723 Ciprofloxacin and dexamethasone
CIPROFLOXACIN AND DEXAMETHASONE
Alembic
July 27, 2026ANDA219234 Prucalopride
PRUCALOPRIDE SUCCINATE
Alembic
June 25, 2026ANDA213414 Dapsone
DAPSONE
Alembic
June 25, 2026ANDA218307 Oseltamivir phosphate
OSELTAMIVIR PHOSPHATE
Alembic
June 11, 2026ANDA214590 Tretinoin
TRETINOIN
Alembic
April 24, 2026ANDA207974 Fingolimod
FINGOLIMOD HYDROCHLORIDE
Alembic
April 15, 2026ANDA220225 Methotrexate
METHOTREXATE SODIUM
Alembic
April 6, 2026ANDA211560 Dapagliflozin
DAPAGLIFLOZIN
Alembic
February 25, 2026ANDA217278 Lamotrigine
LAMOTRIGINE
Alembic
February 5, 2026ANDA218535 Carbidopa, levodopa and entacapone
CARBIDOPA, LEVODOPA AND ENTACAPONE
Alembic
January 26, 2026ANDA213774 Difluprednate
DIFLUPREDNATE
Alembic
December 17, 2025ANDA214687 Travoprost ophthalmic solution
TRAVOPROST
Alembic
December 10, 2025ANDA217597 Loteprednol etabonate and tobramycin
LOTEPREDNOL ETABONATE AND TOBRAMYCIN
Alembic
November 14, 2025ANDA217633 Diltiazem
DILTIAZEM HYDROCHLORIDE
Alembic
November 12, 2025ANDA219115 Dexlansoprazole
DEXLANSOPRAZOLE
Alembic
November 6, 2025ANDA213518 Sumatriptan
SUMATRIPTAN SUCCINATE (AUTOINJECTOR)
Alembic
November 6, 2025ANDA216261 Dasatinib
DASATINIB
Alembic
October 17, 2025ANDA218601 Triamcinolone acetonide
TRIAMCINOLONE ACETONIDE
Alembic
September 24, 2025ANDA217280 Paroxetine
PAROXETINE HYDROCHLORIDE
Alembic
September 8, 2025ANDA216444 Phytonadione
PHYTONADIONE
Alembic
August 18, 2025ANDA211128 Macitentan
MACITENTAN
Alembic
August 14, 2025ANDA218399 Tretinoin
TRETINOIN
Alembic
July 25, 2025ANDA219939 Carbamazepine
CARBAMAZEPINE
Alembic
June 27, 2025ANDA219199 Doxorubicin hydrochloride
DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL)
Alembic
May 23, 2025ANDA209543 Bosutinib
BOSUTINIB MONOHYDRATE
Alembic
Show the other 100 applications
ApprovedApplicationMedicineSponsor
May 22, 2025ANDA217279 Amlodipine and atorvastatin
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM
Alembic
May 14, 2025ANDA210301 Rivaroxaban
RIVAROXABAN
Alembic
May 2, 2025ANDA208576 Ticagrelor
TICAGRELOR
Alembic
April 16, 2025ANDA216623 Carbamazepine
CARBAMAZEPINE
Alembic
March 31, 2025ANDA219230 Pantoprazole sodium
PANTOPRAZOLE SODIUM
Alembic
December 19, 2024ANDA218793 Divalproex sodium
DIVALPROEX SODIUM
Alembic
November 8, 2024ANDA215238 Ivabradine
IVABRADINE HYDROCHLORIDE
Alembic
November 8, 2024ANDA216968 Diltiazem
DILTIAZEM HYDROCHLORIDE
Alembic
October 18, 2024ANDA218587 Diltiazem
DILTIAZEM HYDROCHLORIDE
Alembic
October 1, 2024ANDA211821 Lamotrigine
LAMOTRIGINE
Alembic
September 26, 2024ANDA218330 Paliperidone
PALIPERIDONE
Alembic
September 4, 2024ANDA215652 Albendazole
ALBENDAZOLE
Alembic
August 22, 2024ANDA215832 Betamethasone valerate
BETAMETHASONE VALERATE
Alembic
August 5, 2024ANDA217774 Acitretin
ACITRETIN
Alembic
August 1, 2024ANDA218554 Nelarabine
NELARABINE
Alembic
July 23, 2024ANDA218173 Fluphenazine hydrochloride
FLUPHENAZINE HYDROCHLORIDE
Alembic
July 8, 2024ANDA214340 Bromfenac
BROMFENAC SODIUM
Alembic
June 27, 2024ANDA217674 Doxycycline
DOXYCYCLINE
Alembic
June 14, 2024ANDA213773 Icatibant
ICATIBANT ACETATE
Alembic
June 14, 2024ANDA215233 Dabigatran etexilate
DABIGATRAN ETEXILATE MESYLATE
Alembic
June 6, 2024ANDA217767 Venlafaxine hydrochloride
VENLAFAXINE HYDROCHLORIDE
Alembic
June 3, 2024ANDA217552 Methotrexate
METHOTREXATE SODIUM
Alembic
May 28, 2024ANDA213682 Sacubitril and valsartan
SACUBITRIL AND VALSARTAN
Alembic
April 29, 2024ANDA217804 Tretinoin
TRETINOIN
Alembic
April 25, 2024ANDA218450 Diazepam
DIAZEPAM
Alembic
April 24, 2024NDA216483 Pivmecillinam
PIVYA
Alembic Therap
April 2, 2024ANDA212466 Clindamycin
CLINDAMYCIN PHOSPHATE
Alembic
November 21, 2023ANDA212361 Acyclovir
ACYCLOVIR
Alembic
October 27, 2023ANDA215718 Dapsone
DAPSONE
Alembic
October 18, 2023ANDA217676 Fluorouracil
FLUOROURACIL
Alembic
September 15, 2023ANDA216969 Chlordiazepoxide hydrochloride and clidinium bromide
CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE
Alembic
August 25, 2023ANDA215230 Brimonidine tartrate and timolol maleate
BRIMONIDINE TARTRATE AND TIMOLOL MALEATE
Alembic
August 24, 2023ANDA215661 Erythromycin
ERYTHROMYCIN
Alembic
August 7, 2023ANDA217269 Guanfacine
GUANFACINE HYDROCHLORIDE
Alembic
August 1, 2023ANDA216909 Brimonidine tartrate
BRIMONIDINE TARTRATE
Alembic
July 18, 2023ANDA217350 Chlorpromazine hydrochloride
CHLORPROMAZINE HYDROCHLORIDE
Alembic
June 15, 2023ANDA215810 Doxercalciferol
DOXERCALCIFEROL
Alembic
June 15, 2023ANDA217198 Carboprost tromethamine
CARBOPROST TROMETHAMINE
Alembic
June 2, 2023ANDA211763 Nadolol
NADOLOL
Alembic
April 5, 2023ANDA214588 Bepotastine
BEPOTASTINE BESILATE
Alembic
March 29, 2023ANDA215225 Brimonidine tartrate
BRIMONIDINE TARTRATE
Alembic
March 6, 2023ANDA217268 Prazosin hydrochloride
PRAZOSIN HYDROCHLORIDE
Alembic
March 3, 2023ANDA217295 Fluorouracil
FLUOROURACIL
Alembic
February 28, 2023ANDA215744 Docetaxel
DOCETAXEL
Alembic
January 4, 2023ANDA204973 Fesoterodine fumarate
FESOTERODINE FUMARATE
Alembic
December 22, 2022ANDA215077 Fulvestrant
FULVESTRANT
Alembic
December 8, 2022ANDA214396 Desonide
DESONIDE
Alembic
November 29, 2022ANDA212506 Diclofenac
DICLOFENAC SODIUM
Alembic
November 18, 2022ANDA216896 Nifedipine
NIFEDIPINE
Alembic
November 10, 2022ANDA215892 Cyclophosphamide
CYCLOPHOSPHAMIDE
Alembic
November 2, 2022ANDA214456 Ketorolac tromethamine
KETOROLAC TROMETHAMINE
Alembic
October 28, 2022ANDA216967 Mesalamine
MESALAMINE
Alembic
October 26, 2022ANDA214635 Glycopyrrolate
GLYCOPYRROLATE
Alembic
October 20, 2022ANDA216874 Paclitaxel
PACLITAXEL
Alembic
August 26, 2022ANDA216262 Chlorthalidone
CHLORTHALIDONE
Alembic
August 4, 2022ANDA214185 Adapalene and benzoyl peroxide
ADAPALENE AND BENZOYL PEROXIDE
Alembic
July 27, 2022ANDA212351 Diclofenac
DICLOFENAC SODIUM
Alembic
May 20, 2022ANDA212708 Pirfenidone
PIRFENIDONE
Alembic
May 10, 2022ANDA214779 Arformoterol tartrate
ARFORMOTEROL TARTRATE
Alembic
April 21, 2022ANDA215838 Clobetasol propionate
CLOBETASOL PROPIONATE
Alembic
April 8, 2022ANDA213923 Lidocaine and prilocaine
LIDOCAINE AND PRILOCAINE
Alembic
March 17, 2022ANDA204974 Lacosamide
LACOSAMIDE
Alembic
March 4, 2022ANDA214186 Nystatin and triamcinolone acetonide
NYSTATIN AND TRIAMCINOLONE ACETONIDE
Alembic
January 31, 2022ANDA210459 Clarithromycin
CLARITHROMYCIN
Alembic
January 4, 2022ANDA212601 Entacapone
ENTACAPONE
Alembic
January 3, 2022ANDA213075 Doxycycline
DOXYCYCLINE HYCLATE
Alembic
November 22, 2021ANDA215078 Formoterol fumarate
FORMOTEROL FUMARATE
Alembic
November 16, 2021ANDA213053 Mupirocin
MUPIROCIN
Alembic
September 3, 2021ANDA212646 Metronidazole
METRONIDAZOLE
Alembic
August 4, 2021ANDA211822 Clomipramine hydrochloride
CLOMIPRAMINE HYDROCHLORIDE
Alembic
July 8, 2021ANDA214719 Erlotinib
ERLOTINIB HYDROCHLORIDE
Alembic
July 7, 2021ANDA209785 Desipramine hydrochloride
DESIPRAMINE HYDROCHLORIDE
Alembic
June 25, 2021ANDA211935 Nitrofurantoin
NITROFURANTOIN
Alembic
June 14, 2021ANDA212882 Testosterone
TESTOSTERONE
Alembic
May 13, 2021ANDA213248 Lurasidone hydrochloride
LURASIDONE HYDROCHLORIDE
Alembic
May 4, 2021ANDA213099 Dorzolamide hydrochloride and timolol maleate
DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE
Alembic
April 21, 2021ANDA215076 Doxepin hydrochloride
DOXEPIN HYDROCHLORIDE
Alembic
March 31, 2021ANDA214090 Nystatin and triamcinolone acetonide
NYSTATIN AND TRIAMCINOLONE ACETONIDE
Alembic
March 3, 2021ANDA213922 Testosterone
TESTOSTERONE
Alembic
February 11, 2021ANDA211574 Treprostinil
TREPROSTINIL
Alembic Global
January 21, 2021ANDA214734 Midodrine hydrochloride
MIDODRINE HYDROCHLORIDE
Alembic
December 10, 2020ANDA206098 Asenapine
ASENAPINE MALEATE
Alembic
December 2, 2020ANDA213251 Metolazone
METOLAZONE
Alembic
October 22, 2020ANDA212942 Timolol
TIMOLOL MALEATE
Alembic
October 21, 2020ANDA212188 Tavaborole
TAVABOROLE
Alembic
October 19, 2020ANDA213842 Fenofibrate
FENOFIBRATE (MICRONIZED)
Alembic
October 15, 2020ANDA214284 Amantadine
AMANTADINE HYDROCHLORIDE
Alembic
August 24, 2020ANDA213632 Desonide
DESONIDE
Alembic
August 4, 2020ANDA214031 Vardenafil
VARDENAFIL HYDROCHLORIDE
Alembic
June 30, 2020ANDA211744 Doxycycline
DOXYCYCLINE HYCLATE
Alembic
June 18, 2020ANDA213508 Adapalene
ADAPALENE
Alembic
May 18, 2020ANDA213290 Clobetasol propionate
CLOBETASOL PROPIONATE
Alembic
May 14, 2020ANDA210536 Doxycycline
DOXYCYCLINE HYCLATE
Alembic
March 4, 2020ANDA210537 Doxycycline
DOXYCYCLINE HYCLATE
Alembic
January 28, 2020ANDA211791 Azithromycin
AZITHROMYCIN
Alembic
January 28, 2020ANDA211792 Azithromycin
AZITHROMYCIN
Alembic
January 27, 2020ANDA211793 Azithromycin
AZITHROMYCIN
Alembic
January 27, 2020ANDA213291 Clobetasol propionate
CLOBETASOL PROPIONATE
Alembic
January 21, 2020ANDA210515 Bimatoprost
BIMATOPROST
Alembic
January 17, 2020ANDA213252 Fenofibrate
FENOFIBRATE
Alembic

Showing the 125 newest of 214 applications. Full lists: Drugs@FDA →

The sponsor is the company that holds the FDA application; it can differ from the labeler.

Recall timeline

2025

  1. December 16, 2025 · Class III · Ongoing · D-0248-2026 · Fesoterodine fumarate

    Failed Impurities/Degradation Specifications: Due to levels of 'Diester Impurity' exceeding the specification limit.

    Fesoterodine Fumarate, Extended-release Tablets, 8 mg, 30 Tablets, Rx only, Manufactured by: Alembic Pharmaceuticals Limited, Panelav 389350, Gujarat, India, Manufactured for: Alembic Pharmaceuticals, Inc., Bedminster, N

  2. October 10, 2025 · Class III · Ongoing · D-0156-2026 · Fesoterodine fumarate

    Failed Impurities/Degradation Specifications: Due to levels of 'Diester Impurity' exceeding the specification limit.

    Fesoterodine Fumarate, Extended-release Tablets, 4 mg, 30-count bottle, Rx only, Manufactured by: Alembic Pharmaceuticals Limited, Panelav 389350, Gujarat, India, Manufactured for: Alembic Pharmaceuticals, Inc., Bedminst

  3. July 25, 2025 · Class II · Ongoing · D-0566-2025 · Doxepin hydrochloride

    CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit.

    Doxepin Hydrochloride Capsules, USP, 10 mg, 100 Capsules, Rx only, Manufactured by: Alembic Pharmaceuticals Limited, Panela v 389350, Gujarat, India, Manufactured for: Alembic Pharmaceuticals, Inc., Bedminster, NJ 07921,

  4. May 9, 2025 · Class II · Ongoing · D-0459-2025 · Celecoxib

    Presence of Foreign Tablets/Capsules; customer complaint found one Tadalafil 5mg tablet inside a sealed 500-count bottle of Celecoxib 200mg capsule

    Celecoxib Capsules, 200 mg, 500-count bottle, Rx only, Manufactured by: Alembic Pharmaceuticals Limited (Formulation Division), Panelav 389350, Gujarat, India, Manufactured for: Alembic Pharmaceuticals, Inc., Bedminster,

  5. May 7, 2025 · Class II · Ongoing · D-0447-2025 · Bromfenac

    Failed Impurities/Degradation Specifications

    Bromfenac Ophthalmic Solution 0.09%, 1.7 mL bottle, Rx only, Sterile, Manufactured for: Alembic Pharmaceuticals, Inc., Bedminster, NJ 07921, USA, Manufactured by Alembic Pharmaceuticals Limitied, Gujarat, India, Made in

2023

  1. July 27, 2023 · Class III · Ongoing · D-1086-2023 · Tobramycin

    Failed Impurities/Degradation Specifications

    Tobramycin Opthalmic Solution USP, 0.3%, 5mL bottle, Rx only, Manufactured for: Alembic Pharmaceuticals, Bedminster, NJ 07921, USA, NDC 62332-518-05

  2. June 22, 2023 · Class II · Ongoing · D-0941-2023 · Diclofenac

    Defective Delivery System

    Diclofenac Sodium Topical Solution USP, 2% w/w, 3.8 FL.OZ.(112 grams) bottles, Rx only, Manufactured for: Alembic Pharmaceuticals, Inc. Bedminster, NJ 07921, USA Manufactured by: Alembic Pharmaceuticals Limited (Derma Di

2021

  1. March 17, 2021 · Class I · Terminated · D-0326-2021 · Telmisartan

    Labeling: Label-mixup

    Telmisartan Tablets, USP 20 mg, 30-count bottles, Rx only, Manufactured by: Alembic Pharmaceuticals Limited (Formulation Division) Panelav 38935, Gujarat, India Manufactured for: Alembic Pharmaceuticals, Inc. 750 Route 2

  2. March 15, 2021 · Class II · Terminated · D-0413-2021 · Bromfenac

    CGMP Deviations: Intermittent exposure to temperature excursion during storage.

    BROMFENAC OPHTHALMIC SOLUTION 0.09% 1.7ML NDC/UPC 62332-508-17; RX; DROPS

  3. March 15, 2021 · Class II · Terminated · D-0412-2021 · Metoprolol tartrate and hydrochlorothiazide

    CGMP Deviations: Intermittent exposure to temperature excursion during storage.

    Metoprolol Tartrate and Hydrochlorothiazide Tablets, USP 50 mg/25 mg 100 Tablets Rx only NDC 62332-115-31 Manufactured for: Alembic Pharmaceuticals, Inc. 750 Route 202, Bridgewater, NJ 08807 USA

Show the 1 older recalls

2020

  1. June 10, 2020 · Class II · Terminated · D-1341-2020 · Aripiprazole

    Labeling: Label mix up: Bottles labeled as aripiprazole 2 mg, 30 count had aripiprazole 5 mg tablets, 100 count.

    Aripiprazole Tablets, USP, 2 mg, 30 Tablets per bottle, Rx only, Manufactured by: Alembic Pharmaceuticals Limited (Formulation Division) Panelav 389350, Gujarat, India Manufactured for: Alembic Pharmaceuticals, Inc. 750

What do the recall classes mean?

Class I: The most serious type: there is a reasonable chance that using the product will cause serious health problems or death.
Class II: Using the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
Class III: Using the product is not likely to cause health problems (for example a labeling or packaging issue).

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  3. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026

FDA Enforcement Report search → · Report an error →